Jill E. Stopfer

4.4k total citations · 1 hit paper
69 papers, 2.6k citations indexed

About

Jill E. Stopfer is a scholar working on Genetics, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jill E. Stopfer has authored 69 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Genetics, 16 papers in Oncology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jill E. Stopfer's work include BRCA gene mutations in cancer (62 papers), Ethics in Clinical Research (14 papers) and Genetic factors in colorectal cancer (11 papers). Jill E. Stopfer is often cited by papers focused on BRCA gene mutations in cancer (62 papers), Ethics in Clinical Research (14 papers) and Genetic factors in colorectal cancer (11 papers). Jill E. Stopfer collaborates with scholars based in United States, Canada and United Kingdom. Jill E. Stopfer's co-authors include Susan M. Domchek, Timothy R. Rebbeck, Katherine L. Nathanson, Judy E. Garber, Barbara L. Weber, Katrina Armstrong, Chanita Hughes Halbert, Barbara Weber, Fergus J. Couch and Lisa Kessler and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Jill E. Stopfer

65 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer

1997 506 citations Fergus J. Couch, Jill E. Stopfer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jill E. Stopfer United States	31	2.1k	627	598	494	467	69	2.6k
Judy Kirk Australia	30	1.3k 0.6×	579 0.9×	826 1.4×	554 1.1×	614 1.3×	107	3.1k
Audrey Ardern‐Jones United Kingdom	24	1.2k 0.6×	688 1.1×	481 0.8×	303 0.6×	224 0.5×	48	2.1k
Marie Wood United States	25	1.0k 0.5×	413 0.7×	848 1.4×	498 1.0×	467 1.0×	79	2.3k
Margreet G.E.M. Ausems Netherlands	35	2.0k 0.9×	744 1.2×	1.0k 1.7×	769 1.6×	638 1.4×	157	3.6k
E.J. Meijers-Heijboer Netherlands	20	1.7k 0.8×	414 0.7×	457 0.8×	616 1.2×	494 1.1×	26	2.0k
June A. Peters United States	21	1.1k 0.5×	586 0.9×	435 0.7×	287 0.6×	232 0.5×	66	2.2k
Charmaine Kim‐Sing Canada	34	2.2k 1.0×	596 1.0×	1.2k 2.1×	1.1k 2.2×	567 1.2×	61	3.7k
Kent Hoskins United States	21	1.3k 0.6×	660 1.1×	712 1.2×	521 1.1×	345 0.7×	74	2.2k
Mary B. Daly United States	18	3.0k 1.4×	787 1.3×	768 1.3×	963 1.9×	744 1.6×	36	3.6k
Kathy Tucker Australia	35	2.4k 1.1×	410 0.7×	744 1.2×	429 0.9×	425 0.9×	142	3.4k

Countries citing papers authored by Jill E. Stopfer

Since Specialization

Citations

This map shows the geographic impact of Jill E. Stopfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill E. Stopfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill E. Stopfer more than expected).

Fields of papers citing papers by Jill E. Stopfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill E. Stopfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill E. Stopfer. The network helps show where Jill E. Stopfer may publish in the future.

Co-authorship network of co-authors of Jill E. Stopfer

This figure shows the co-authorship network connecting the top 25 collaborators of Jill E. Stopfer. A scholar is included among the top collaborators of Jill E. Stopfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill E. Stopfer. Jill E. Stopfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weiss, Anna, Mário Antonello Rosito, Danielle Braun, et al.. (2025). Impact of the American Society of Breast Surgeons’ Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy Rates. Annals of Surgical Oncology. 32(6). 3965–3974.

Bradbury, Angela R., Brian L. Egleston, Linda Patrick‐Miller, et al.. (2020). Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients. Clinical Genetics. 97(4). 601–609. 8 indexed citations

Bradbury, Angela R., Linda Patrick‐Miller, Diana Harris, et al.. (2016). Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study. Journal of Medical Internet Research. 18(2). e23–e23. 75 indexed citations

Bradbury, Angela R., Linda Patrick‐Miller, Brian L. Egleston, et al.. (2015). Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing. Genetics in Medicine. 18(1). 25–33. 46 indexed citations

Schmitz, Kathryn H., Nancy I. Williams, Despina Kontos, et al.. (2015). Women In Steady Exercise Research (WISER) Sister: Study design and methods. Contemporary Clinical Trials. 41. 17–30. 20 indexed citations

Feero, W, Flavia M. Facio, Emily Glogowski, et al.. (2014). Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon General’s My Family Health Portrait. Genetics in Medicine. 17(9). 753–756. 7 indexed citations

Maxwell, Kara N., Bradley Wubbenhorst, Kurt D’Andrea, et al.. (2014). Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. Genetics in Medicine. 17(8). 630–638. 106 indexed citations

Domchek, Susan M., Jiang-bo Tang, Jill E. Stopfer, et al.. (2012). Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer. Cancer Discovery. 3(4). 399–405. 101 indexed citations

Neklason, Deborah W., Ann G. Schwartz, Hoda Anton‐Culver, et al.. (2011). Activating mutation in MET oncogene in familial colorectal cancer. BMC Cancer. 11(1). 424–424. 37 indexed citations

10.

Cohen, Justine V., Laura Chiel, Jill E. Stopfer, et al.. (2011). Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy. Familial Cancer. 11(1). 69–75. 44 indexed citations

11.

Palma, Maurizia Dalla, Susan M. Domchek, Jill E. Stopfer, et al.. (2008). The Relative Contribution of Point Mutations and Genomic Rearrangements in BRCA1 and BRCA2 in High-Risk Breast Cancer Families. Cancer Research. 68(17). 7006–7014. 82 indexed citations

12.

Neklason, Deborah W., Richard A. Kerber, Hoda Anton‐Culver, et al.. (2008). Common Familial Colorectal Cancer Linked to Chromosome 7q31: A Genome-Wide Analysis. Cancer Research. 68(21). 8993–8997. 27 indexed citations

13.

Finlay, Esmé, Jill E. Stopfer, Katherine G. Evans, et al.. (2008). Factors Determining Dissemination of Results and Uptake of Genetic Testing in Families with Known BRCA1/2 Mutations. Genetic Testing. 12(1). 81–91. 128 indexed citations

14.

Halbert, Chanita Hughes, Lisa Kessler, E. Paul Wileyto, et al.. (2006). Breast cancer screening behaviors among African American women with a strong family history of breast cancer. Preventive Medicine. 43(5). 385–388. 30 indexed citations

15.

Peters, Nikki, et al.. (2005). Knowledge, Attitudes, and Utilization of BRCA1/2 Testing among Women with Early-Onset Breast Cancer. Genetic Testing. 9(1). 48–53. 41 indexed citations

16.

Volpe, Patrícia, et al.. (2004). Characterization of Two Novel BRCA1 Germ-Line Mutations Involving Splice Donor Sites. Genetic Testing. 8(2). 133–138. 16 indexed citations

17.

Schneider, Katherine A., L. Digianni, Andrea Farkas Patenaude, et al.. (2004). Accuracy of Cancer Family Histories: Comparison of Two Breast Cancer Syndromes. Genetic Testing. 8(3). 222–228. 35 indexed citations

18.

Armstrong, Katrina, et al.. (2002). What Does My Doctor Think? Preferences for Knowing the Doctor's Opinion Among Women Considering Clinical Testing for BRCA1 / 2 Mutations. Genetic Testing. 6(2). 115–118. 26 indexed citations

19.

Armstrong, Katrina, Barbara Weber, Jill E. Stopfer, et al.. (2002). Early use of clinical BRCA1/2 testing: Associations with race and breast cancer risk. American Journal of Medical Genetics Part A. 117A(2). 154–160. 40 indexed citations

20.

Stopfer, Jill E.. (2000). Genetic counseling and clinical cancer genetics services. Seminars in Surgical Oncology. 18(4). 347–357. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact